CD8A and cancer: Elevated peripheral CD8+ T-cell counts or high CD4+/CD8+ ratios have been associated with improved outcomes in various cancers treated with ICIs, while in some studies they are associated with increased incidence and severity of irAEs [56,57,58,59].